Ticagrelor and Endothelial Function

NCT02261922 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Antiplatelet Agents; Endothelial Function; Pleotropic Effects

Interventions

DRUG: ticagrelor
DRUG: prasugrel

Sponsor

Hotel Dieu de France Hospital